As of Dec 12
| -0.23 / -1.86%|
The 3 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 15.00, with a high estimate of 16.00 and a low estimate of 14.00. The median estimate represents a +23.76% increase from the last price of 12.12.
The current consensus among 3 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.